Pricing Log in Create free account
Friday 6 November 2026 Export LQDA’s income statement to Excel — free account

Liquidia Corporation

LQDA Healthcare Drug Manufacturers Specialty & Generic

Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.

Revenue
+1,842.7%
EPS
+271.4%
Free cash flow
+270.2%
Total debt
−9.04%

Quarter to June 2026, against a year earlier

45.54 1.05 +2.36%
Market cap
$4.0B
P/E
28.5×
Fwd P/E
22.1×
Dividend yield
—
F-score
5/9
Altman Z
4.08
Beneish M
6.79
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Liquidia Corporation (LQDA) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Liquidia Corporation (LQDA) trades at a P/S ratio of 8.8×. Over the past ten years it has ranged from 1.2× (July 2018) to 129× (September 2025); the current reading is higher than 10% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.1× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 18.7× (71.65%)
FY2024 66.1× 54.34%
FY2023 42.9× 83.93%
FY2022 23.3× 17.27%
FY2022 19.9× 5.54%
FY2021 18.8× 82.43%
FY2021 10.3× 1.70%
FY2020 10.1× 22.93%
FY2020 8.3× 2.80%
FY2019 8.0× (84.98%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 15.7× 36.32%
Mar 2026 11.5× (38.50%)
Dec 2025 18.7× (33.90%)
Sep 2025 28.4× (48.61%)
25 more quarters

Against its own ten years

Low 1.2× High 129×
Ten-year median 23.6×
Current reading's percentile 10

P/S ratio against peers

Company P/S ratio
HCM HUTCHMED (China) Limited Sponsored ADR compare n/m
PBH Prestige Consumer Healthcare Inc. compare 1.8×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 2.0×
HIMS Hims & Hers Health, Inc. compare 2.2×
SUPN Indivior Pharmaceuticals Inc. compare 2.4×
LNTH Lantheus Holdings, Inc. compare 4.2×
LQDA Liquidia Corporation 8.8×
AMLX Amylyx Pharmaceuticals, Inc. compare 35.4×
RGC Regencell Bioscience Holdings Limited compare —
Drug Manufacturers Specialty & Generic industry median 2.1×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on LQDA